{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:04:05Z","timestamp":1794953045074,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We have previously shown that exon 1 of the huntingtin gene does not always splice to exon 2 resulting in the production of a small polyadenylated mRNA (\n                    <jats:italic>HTTexon1<\/jats:italic>\n                    ) that encodes the highly pathogenic exon 1 HTT protein. The level of this read-through product is proportional to CAG repeat length and is present in all knock-in mouse models of Huntington\u2019s disease (HD) with CAG lengths of 50 and above and in the YAC128 and BACHD mouse models, both of which express a copy of the human\n                    <jats:italic>HTT<\/jats:italic>\n                    gene. We have now developed specific protocols for the quantitative analysis of the transcript levels of\n                    <jats:italic>HTTexon1<\/jats:italic>\n                    in human tissue and applied these to a series of fibroblast lines and\n                    <jats:italic>post-mortem<\/jats:italic>\n                    brain samples from individuals with either adult-onset or juvenile-onset HD. We found that the\n                    <jats:italic>HTTexon1<\/jats:italic>\n                    mRNA is present in fibroblasts from juvenile HD patients and can also be readily detected in the sensory motor cortex, hippocampus and cerebellum of\n                    <jats:italic>post-mortem<\/jats:italic>\n                    brains from HD individuals, particularly in those with early onset disease. This finding will have important implications for strategies to lower mutant\n                    <jats:italic>HTT<\/jats:italic>\n                    levels in patients and the design of future therapeutics.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-01510-z","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T06:11:28Z","timestamp":1493100688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":244,"title":["The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Andreas","family":"Neueder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Landles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhia","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Howland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8365-2674","authenticated-orcid":false,"given":"Richard H.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L. M.","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-6305","authenticated-orcid":false,"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"1510_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME Macdonald","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group. A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntingtons-Disease Chromosomes. Cell \n                           72, 971\u2013983, doi:10.1016\/0092-8674(93)90585-E (1993).","journal-title":"Cell"},{"key":"1510_CR2","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nature reviews. Disease primers \n                           1, 15005, doi:10.1038\/nrdp.2015.5 (2015).","journal-title":"Nature reviews. Disease primers"},{"key":"1510_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi, M. A., Morton, A. J. & Hayden, M. R. Choosing an animal model for the study of Huntington\u2019s disease. Nature reviews. Neuroscience \n                           14, 708\u2013721, doi:10.1038\/nrn3570 (2013).","journal-title":"Nature reviews. Neuroscience"},{"key":"1510_CR4","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K. et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci USA \n                           110, 2366\u20132370, doi:10.1073\/pnas.1221891110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1510_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell \n                           87, 493\u2013506, doi:10.1016\/S0092-8674(00)81369-0 (1996).","journal-title":"Cell"},{"key":"1510_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/hmg\/ddu504","volume":"24","author":"BA Barbaro","year":"2015","unstructured":"Barbaro, B. A. et al. Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington\u2019s disease. Hum Mol Genet \n                           24, 913\u2013925, doi:10.1093\/hmg\/ddu504 (2015).","journal-title":"Hum Mol Genet"},{"key":"1510_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science \n                           277, 1990\u20131993, doi:10.1126\/science.277.5334.1990 (1997).","journal-title":"Science"},{"key":"1510_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes, A. et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Molecular cell \n                           10, 259\u2013269, doi:10.1016\/S1097-2765(02)00602-0 (2002).","journal-title":"Molecular cell"},{"key":"1510_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/nen.0b013e318040b2c8","volume":"66","author":"G Schilling","year":"2007","unstructured":"Schilling, G. et al. Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. Journal of neuropathology and experimental neurology \n                           66, 313\u2013320, doi:10.1097\/nen.0b013e318040b2c8 (2007).","journal-title":"Journal of neuropathology and experimental neurology"},{"key":"1510_CR10","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science \n                           302, 1978\u20131980, doi:10.1126\/science.1088583 (2003).","journal-title":"Science"},{"key":"1510_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/hmg\/11.7.805","volume":"11","author":"M Fardaei","year":"2002","unstructured":"Fardaei, M. et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet \n                           11, 805\u2013814, doi:10.1093\/hmg\/11.7.805 (2002).","journal-title":"Hum Mol Genet"},{"key":"1510_CR12","doi-asserted-by":"publisher","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf, A. et al. RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression. PLoS One \n                           10, e0143563, doi:10.1371\/journal.pone.0143563 (2015).","journal-title":"PLoS One"},{"key":"1510_CR13","doi-asserted-by":"publisher","first-page":"e0141298","DOI":"10.1371\/journal.pone.0141298","volume":"10","author":"AT Labadorf","year":"2015","unstructured":"Labadorf, A. T. & Myers, R. H. Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing. PLoS One \n                           10, e0141298, doi:10.1371\/journal.pone.0141298 (2015).","journal-title":"PLoS One"},{"key":"1510_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges, A. et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet \n                           15, 965\u2013977, doi:10.1093\/hmg\/ddl013 (2006).","journal-title":"Hum Mol Genet"},{"key":"1510_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12920-014-0060-2","volume":"7","author":"A Neueder","year":"2014","unstructured":"Neueder, A. & Bates, G. P. A common gene expression signature in Huntington\u2019s disease patient brain regions. BMC medical genomics \n                           7, 60, doi:10.1186\/s12920-014-0060-2 (2014).","journal-title":"BMC medical genomics"},{"key":"1510_CR16","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn, A. et al. Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet \n                           16, 1845\u20131861, doi:10.1093\/hmg\/ddm133 (2007).","journal-title":"Hum Mol Genet"},{"key":"1510_CR17","doi-asserted-by":"publisher","first-page":"e1004550","DOI":"10.1371\/journal.pgen.1004550","volume":"10","author":"M Mielcarek","year":"2014","unstructured":"Mielcarek, M. et al. Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease. PLoS Genet \n                           10, e1004550, doi:10.1371\/journal.pgen.1004550 (2014).","journal-title":"PLoS Genet"},{"key":"1510_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fernandez-Nogales","year":"2014","unstructured":"Fernandez-Nogales, M. et al. Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods. Nature medicine \n                           20, 881\u2013885, doi:10.1038\/nm.3617 (2014).","journal-title":"Nature medicine"},{"key":"1510_CR19","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jmb.2013.12.028","volume":"426","author":"AC Hughes","year":"2014","unstructured":"Hughes, A. C. et al. Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling. Journal of molecular biology \n                           426, 1428\u20131438, doi:10.1016\/j.jmb.2013.12.028 (2014).","journal-title":"Journal of molecular biology"},{"key":"1510_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JHD-150151","volume":"4","author":"M Mort","year":"2015","unstructured":"Mort, M. et al. Huntingtin Exists as Multiple Splice Forms in Human Brain. Journal of Huntington\u2019s disease \n                           4, 161\u2013171, doi:10.3233\/JHD-150151 (2015).","journal-title":"Journal of Huntington\u2019s disease"},{"key":"1510_CR21","doi-asserted-by":"publisher","first-page":"e0127687","DOI":"10.1371\/journal.pone.0127687","volume":"10","author":"A Ruzo","year":"2015","unstructured":"Ruzo, A. et al. Discovery of novel isoforms of huntingtin reveals a new hominid-specific exon. PLoS One \n                           10, e0127687, doi:10.1371\/journal.pone.0127687 (2015).","journal-title":"PLoS One"},{"key":"1510_CR22","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4161\/rna.26706","volume":"10","author":"TA Gipson","year":"2013","unstructured":"Gipson, T. A., Neueder, A., Wexler, N. S., Bates, G. P. & Housman, D. Aberrantly spliced HTT, a new player in Huntington\u2019s disease pathogenesis. RNA biology \n                           10, 1647\u20131652, doi:10.4161\/rna.26706 (2013).","journal-title":"RNA biology"},{"key":"1510_CR23","doi-asserted-by":"publisher","first-page":"34836","DOI":"10.1074\/jbc.M204345200","volume":"277","author":"A Bibillo","year":"2002","unstructured":"Bibillo, A. & Eickbush, T. H. High processivity of the reverse transcriptase from a non-long terminal repeat retrotransposon. The Journal of biological chemistry \n                           277, 34836\u201334845, doi:10.1074\/jbc.M204345200 (2002).","journal-title":"The Journal of biological chemistry"},{"key":"1510_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-015-0018-7","volume":"10","author":"MM Evers","year":"2015","unstructured":"Evers, M. M. et al. Making (anti-) sense out of huntingtin levels in Huntington disease. Molecular neurodegeneration \n                           10, 21, doi:10.1186\/s13024-015-0018-7 (2015).","journal-title":"Molecular neurodegeneration"},{"key":"1510_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1101\/gad.261974.115","volume":"29","author":"Y Shi","year":"2015","unstructured":"Shi, Y. & Manley, J. L. The end of the message: multiple protein-RNA interactions define the mRNA polyadenylation site. Genes Dev \n                           29, 889\u2013897, doi:10.1101\/gad.261974.115 (2015).","journal-title":"Genes Dev"},{"key":"1510_CR26","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss, A. et al. Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. The Journal of clinical investigation \n                           122, 3731\u20133736, doi:10.1172\/JCI64565 (2012).","journal-title":"The Journal of clinical investigation"},{"key":"1510_CR27","doi-asserted-by":"publisher","unstructured":"Wetzel, R. & Mishra, R. Structural Biology: Huntington\u2019s Disease. Oxford University Press 274\u2013322, doi:10.1093\/med\/9780199929146.003.0012 (2014).","DOI":"10.1093\/med\/9780199929146.003.0012"},{"key":"1510_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/bse0560167","volume":"56","author":"P Trepte","year":"2014","unstructured":"Trepte, P., Strempel, N. & Wanker, E. E. Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures. Essays in biochemistry \n                           56, 167\u2013180, doi:10.1042\/bse0560167 (2014).","journal-title":"Essays in biochemistry"},{"key":"1510_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/ng0494-409","volume":"6","author":"H Telenius","year":"1994","unstructured":"Telenius, H. et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet \n                           6, 409\u2013414, doi:10.1038\/ng0494-409 (1994).","journal-title":"Nat Genet"},{"key":"1510_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat Genet \n                           15, 197\u2013200, doi:10.1038\/ng0297-197 (1997).","journal-title":"Nat Genet"},{"key":"1510_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2015.01.004","volume":"76","author":"E Larson","year":"2015","unstructured":"Larson, E., Fyfe, I., Morton, A. J. & Monckton, D. G. Age-, tissue- and length-dependent bidirectional somatic CAG*CTG repeat instability in an allelic series of R6\/2 Huntington disease mice. Neurobiology of disease \n                           76, 98\u2013111, doi:10.1016\/j.nbd.2015.01.004 (2015).","journal-title":"Neurobiology of disease"},{"key":"1510_CR32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/hmg\/ddm054","volume":"16","author":"PF Shelbourne","year":"2007","unstructured":"Shelbourne, P. F. et al. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum Mol Genet \n                           16, 1133\u20131142, doi:10.1093\/hmg\/ddm054 (2007).","journal-title":"Hum Mol Genet"},{"key":"1510_CR33","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1073\/pnas.0800048105","volume":"105","author":"R Gonitel","year":"2008","unstructured":"Gonitel, R. et al. DNA instability in postmitotic neurons. Proc Natl Acad Sci USA \n                           105, 3467\u20133472, doi:10.1073\/pnas.0800048105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1510_CR34","doi-asserted-by":"publisher","first-page":"e23647","DOI":"10.1371\/journal.pone.0023647","volume":"6","author":"JM Lee","year":"2011","unstructured":"Lee, J. M., Pinto, R. M., Gillis, T., St Claire, J. C. & Wheeler, V. C. Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver. PLoS One \n                           6, e23647, doi:10.1371\/journal.pone.0023647 (2011).","journal-title":"PLoS One"},{"key":"1510_CR35","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","volume":"18","author":"M Swami","year":"2009","unstructured":"Swami, M. et al. Somatic expansion of the Huntington\u2019s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet \n                           18, 3039\u20133047, doi:10.1093\/hmg\/ddp242 (2009).","journal-title":"Hum Mol Genet"},{"key":"1510_CR36","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.26020","volume":"29","author":"N Aronin","year":"2014","unstructured":"Aronin, N. & DiFiglia, M. Huntingtin-lowering strategies in Huntington\u2019s disease: antisense oligonucleotides, small RNAs, and gene editing. Movement disorders: official journal of the Movement Disorder Society \n                           29, 1455\u20131461, doi:10.1002\/mds.26020 (2014).","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"1510_CR37","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/mds.26007","volume":"29","author":"EJ Wild","year":"2014","unstructured":"Wild, E. J. & Tabrizi, S. J. Targets for future clinical trials in Huntington\u2019s disease: what\u2019s in the pipeline? Movement disorders: official journal of the Movement Disorder Society \n                           29, 1434\u20131445, doi:10.1002\/mds.26007 (2014).","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"1510_CR38","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz, H. B. et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron \n                           74, 1031\u20131044, doi:10.1016\/j.neuron.2012.05.009 (2012).","journal-title":"Neuron"},{"key":"1510_CR39","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin. Molecular therapy: the journal of the American Society of Gene Therapy \n                           19, 2178\u20132185, doi:10.1038\/mt.2011.201 (2011).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"1510_CR40","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S. Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA \n                           102, 5820\u20135825, doi:10.1073\/pnas.0501507102 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1510_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/hum.2013.200","volume":"25","author":"LM Stanek","year":"2014","unstructured":"Stanek, L. M. et al. Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington\u2019s disease. Human gene therapy \n                           25, 461\u2013474, doi:10.1089\/hum.2013.200 (2014).","journal-title":"Human gene therapy"},{"key":"1510_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","volume":"137","author":"U Trager","year":"2014","unstructured":"Trager, U. et al. HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NFkappaB pathway dysregulation. Brain: a journal of neurology \n                           137, 819\u2013833, doi:10.1093\/brain\/awt355 (2014).","journal-title":"Brain: a journal of neurology"},{"key":"1510_CR43","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/hmg\/10.21.2425","volume":"10","author":"K Sathasivam","year":"2001","unstructured":"Sathasivam, K. et al. Centrosome disorganization in fibroblast cultures derived from R6\/2 Huntington\u2019s disease (HD) transgenic mice and HD patients. Hum Mol Genet \n                           10, 2425\u20132435, doi:10.1093\/hmg\/10.21.2425 (2001).","journal-title":"Hum Mol Genet"},{"key":"1510_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods \n                           25, 402\u2013408, doi:10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"1510_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","volume":"72","author":"B Woodman","year":"2007","unstructured":"Woodman, B. et al. The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain research bulletin \n                           72, 83\u201397, doi:10.1016\/j.brainresbull.2006.11.004 (2007).","journal-title":"Brain research bulletin"},{"key":"1510_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S. & Chesselet, M. F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. The Journal of comparative neurology \n                           465, 11\u201326, doi:10.1002\/cne.10776 (2003).","journal-title":"The Journal of comparative neurology"},{"key":"1510_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","volume":"61","author":"E Hockly","year":"2003","unstructured":"Hockly, E., Woodman, B., Mahal, A., Lewis, C. M. & Bates, G. Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse. Brain research bulletin \n                           61, 469\u2013479, doi:10.1016\/S0361-9230(03)00185-0 (2003).","journal-title":"Brain research bulletin"},{"key":"1510_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/hmg\/ddp467","volume":"19","author":"K Sathasivam","year":"2010","unstructured":"Sathasivam, K. et al. Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington\u2019s disease. Human molecular genetics \n                           19, 65\u201378, doi:10.1093\/Hmg\/Ddp467 (2010).","journal-title":"Human molecular genetics"},{"key":"1510_CR49","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1107\/S1744309105036547","volume":"61","author":"C Peters-Libeu","year":"2005","unstructured":"Peters-Libeu, C. et al. Crystallization and diffraction properties of the Fab fragment of 3B5H10, an antibody specific for disease-causing polyglutamine stretches. Acta crystallographica. Section F, Structural biology and crystallization communications \n                           61, 1065\u20131068, doi:10.1107\/S1744309105036547 (2005).","journal-title":"Section F, Structural biology and crystallization communications"},{"key":"1510_CR50","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/hmg\/10.21.2425","volume":"10","author":"K Sathasivam","year":"2001","unstructured":"Sathasivam, K. et al. Centrosome disorganization in fibroblast cultures derived from R6\/2 Huntington\u2019s disease (HD) transgenic mice and HD patients. Human molecular genetics \n                           10, 2425\u20132435, doi:10.1093\/hmg\/10.21.2425 (2001).","journal-title":"Human molecular genetics"},{"key":"1510_CR51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","volume":"56","author":"J Ko","year":"2001","unstructured":"Ko, J., Ou, S. & Patterson, P. H. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain research bulletin \n                           56, 319\u2013329, doi:10.1016\/S0361-9230(01)00599-8 (2001).","journal-title":"Brain research bulletin"},{"key":"1510_CR52","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles, C. et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. The Journal of biological chemistry \n                           285, 8808\u20138823, doi:10.1074\/jbc.M109.075028 (2010).","journal-title":"The Journal of biological chemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01510-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T22:51:58Z","timestamp":1671749518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01510-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01510-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]},"assertion":[{"value":"3 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1307"}}